arrow
Y

Yasuhito Nannya

the university of tokyo
H指数:51
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Combination Therapy of Vinblastine, Prednisolone, Methotrexate, and 6-Mercaptopurine as a Front-Line Therapy for Adult Patients With Langerhans Cell Histiocytosis

长春碱、泼尼松、甲氨蝶呤和6-巯基嘌呤联合疗法作为成人朗格汉斯细胞组织细胞增生症的初始一线治疗

2026-10-170
OAAI
Functional Classification of Monoallelic TP53 Mutations Refines Prognostic Stratification in Myelodysplastic Neoplasms

单等位基因TP53突变的功能分类细化了骨髓增生异常性肿瘤的预后分层

Blood
IF23.1
2026-10-060
OAAI
Multiomics analysis focusing on genome-wide DNA methylation in paediatric acute promyelocytic leukaemia

多组学分析聚焦于儿科急性早幼粒细胞白血病全基因组DNA甲基化

2026-08-210
PRE
Clonal hematopoiesis related to ionizing radiation in atomic bomb survivors

原子弹幸存者中与电离辐射相关的克隆性造血

Leukemia
IF13.4
2026-08-120
OAAI
Pre-transplant molecular international prognostic scoring system score reduction is not associated with improved outcomes in myelodysplastic syndromes

移植前分子国际预后评分系统评分降低与骨髓增生异常综合征的预后改善无关

2026-07-270
OAAI
Lifelong phylogenetic reconstruction of immune-mediated clonal trajectories in paroxysmal nocturnal hemoglobinuria

在阵发性睡眠性血红蛋白尿症中免疫介导的克隆轨迹的终身系统发育重建

Leukemia
IF13.4
2026-07-130
PRE
Clinical impact of pre-transplant estimated glomerular filtration rate using the CKD-EPI equation with serum creatinine on outcomes after single-unit cord blood transplantation in adults

成人单份脐带血移植后,使用血清肌酐的CKD-EPI方程估算的移植前肾小球滤过率对预后的临床影响

2026-07-030
PRE
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax—an analysis from the International Consortium for MDS (icMDS) VALIDATE database

高风险骨髓增生异常综合征/新生物患者接受去甲基化药物+维奈克拉治疗后的结局分析——国际骨髓增生异常综合征(icMDS)VALIDATE数据库分析

2026-06-290
OAAI
A diagnostic pitfall in cold agglutinin disease: KMT2D-mutated CAD-associated lymphoproliferative disorder with a CLL-like immunophenotype

冷凝集素病中的诊断陷阱:KMT2D突变型CAD相关淋巴细胞增生性病变,具有CLL样免疫表型

2026-05-011
PRE
NUP98 rearrangements in adult AML patients: evaluation of clinical implications and identification of novel fusion partners

NUP98重排在大AML患者中的临床意义评估及新型融合伴侣的鉴定

Leukemia
IF13.4
2026-01-070
PRE
DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study

DDX41突变髓系肿瘤挑战现有的预后方案,并需要专门的危险评分系统:一项多中心、回顾性研究

Leukemia
IF13.4
2025-12-030
PRE
Recipient polymorphism of the C-reactive protein (CRP) gene rs2794521 stratified disease-free survival, but did not influence maximum serum CRP levels during neutropenia after single-unit cord blood transplantation in adults

C-reactive protein (CRP)基因的受体多态性位点rs2794521分层了无病生存期,但并未影响成人单份脐带血移植后中性粒细胞减少期间血清CRP的最高水平。

2025-12-010
PRE
Chromatin accessibility in stem cells unveils progressive transcriptional alterations in myelodysplastic syndrome

干细胞中的染色质可及性揭示了骨髓增生异常综合征中渐进性的转录改变

2025-11-280
OAAI
Comorbidities and mutations including single- and multihit TET2 mutations in relation to outcome in chronic myelomonocytic leukaemia—A population-based study

合并症和突变,包括单次和多次打击的TET2突变,与慢性骨髓单核细胞白血病预后的关系——一项基于人群的研究

2025-11-250
OAAI
Elevation of White Blood Cell Count after G-CSF–Combined Conditioning Predicts Relapse and Disease-Free Survival Following Single-Unit Cord Blood Transplantation for Myeloid Malignancies

G-CSF联合预处理后白细胞计数升高可预测髓系恶性肿瘤行单份脐带血移植后的复发及无病生存情况

2025-11-120
OAAI
Assessment of cellular and humoral immunity against varicella-zoster virus in adult allogeneic hematopoietic cell transplant recipients: a cross-sectional study assessing cellular immunity after administration of an adjuvanted recombinant zoster vaccine

评估成人异基因造血细胞移植受者对水痘-带状疱疹病毒的细胞和体液免疫:一项评估加佐剂重组带状疱疹疫苗给药后细胞免疫的横断面研究

2025-11-010
PRE